The Trump administration on Thursday, February 5, 2026, launched TrumpRx.gov, a government-hosted website that directs patients to manufacturer programs and pharmacy coupons offering discounted prices on 43 brand-name prescription drugs. The initial list focuses on cash-paying patients with valid prescriptions, with the White House saying additional drugs will be added in the coming months.
On Thursday, February 5, 2026, the Trump administration unveiled TrumpRx.gov, a federal website it says will help patients access discounted prices on prescription drugs.
While the White House describes TrumpRx as a way for patients to pay prices aligned with “most-favored-nation” levels, the site does not function as an online pharmacy. Instead, it acts as a portal that routes users to drugmakers’ direct-to-consumer purchasing options and, in some cases, provides coupons that can be used at retail pharmacies.
At launch, TrumpRx listed 43 drugs from five manufacturers that reached pricing agreements with the administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer, according to the White House and NPR. The administration has said additional drugs from other companies that signed similar agreements will be added in the coming months.
The discounts are aimed primarily at people paying out of pocket. Some offers require users to attest they are not enrolled in government insurance programs such as Medicare and that they will not seek reimbursement for purchases made using the coupons.
Among the higher-profile medications highlighted by the White House are the GLP-1 drugs Ozempic and injectable Wegovy, which the White House said can be offered as low as $199 per month for eligible patients depending on dosage, and Zepbound, which it said can be as low as $299 per month depending on dosage. The White House also cited fertility drugs, including Gonal-F priced as low as $168 per pen depending on dosage, as well as insulin lispro available for as low as $25 per month.
President Donald Trump, speaking at the rollout, argued the new platform followed years of unfulfilled promises to reduce drug costs. “For years, politicians from both parties have promised to bring down prescription drug prices and make health care more affordable, but they all failed. It was all words, as usual,” Trump said. “But I’m actually getting it done; it is done, actually.”
The White House has framed the launch as the start of a broader expansion, saying it is pursuing additional agreements and plans to add more discounted drugs over time.
Some health-policy analysts and news organizations have cautioned that the savings may vary widely depending on a patient’s insurance status and whether lower-cost generic alternatives are already available elsewhere, limiting the site’s usefulness for many insured consumers.
